Kari Pulkki

15.9k total citations · 1 hit paper
206 papers, 8.0k citations indexed

About

Kari Pulkki is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Epidemiology. According to data from OpenAlex, Kari Pulkki has authored 206 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 43 papers in Oncology and 36 papers in Epidemiology. Recurrent topics in Kari Pulkki's work include Sepsis Diagnosis and Treatment (21 papers), Acute Myocardial Infarction Research (20 papers) and Neutropenia and Cancer Infections (18 papers). Kari Pulkki is often cited by papers focused on Sepsis Diagnosis and Treatment (21 papers), Acute Myocardial Infarction Research (20 papers) and Neutropenia and Cancer Infections (18 papers). Kari Pulkki collaborates with scholars based in Finland, United States and United Kingdom. Kari Pulkki's co-authors include Liisa‐Maria Voipio‐Pulkki, Antti Saraste, Markku Kallajoki, Kim Pettersson, Martti Parvinen, Kenth Henriksén, Esko Ruokonen, M. Parvinen, Olli Arola and Pekka Porela and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Kari Pulkki

202 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apoptosis in Human Acute Myocardial Infarction

1997 683 citations Antti Saraste, Kari Pulkki et al. profile →

Peers

Countries citing papers authored by Kari Pulkki

Since Specialization

Citations

This map shows the geographic impact of Kari Pulkki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Pulkki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Pulkki more than expected).

Fields of papers citing papers by Kari Pulkki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Pulkki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Pulkki. The network helps show where Kari Pulkki may publish in the future.

Co-authorship network of co-authors of Kari Pulkki

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Pulkki. A scholar is included among the top collaborators of Kari Pulkki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Pulkki. Kari Pulkki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-sensitivity cardiac troponin T and N-terminal b-type natriuretic propeptide are associated with cardiac and all-cause mortality in older adults – A population-based ten-year follow-up study 2024 ·Clinica Chimica Acta ·(unknown), (unknown), Marika Salminen, Kerttu Irjala, (unknown), Marja-Kaisa Koivula, Kari Pulkki, Matti Viitanen, Tero Vahlberg, Laura Viikari	1
2	Novel biomarkers to identify complicated course of febrile neutropenia in hematological patients receiving intensive chemotherapy 2024 ·European Journal Of Haematology ·Esa Jantunen, Sari Hämäläinen, Kari Pulkki, Auni Juutilainen	4
3	Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia 2021 ·Clinical and Experimental Medicine ·(unknown), (unknown), (unknown), (unknown), Sari Hämäläinen, Kari Pulkki, Esa Jantunen, Auni Juutilainen, Anna‐Kaisa Purhonen	5
4	Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study 2020 ·Clinica Chimica Acta ·Angelika Hammerer‐Lercher, Damien Gruson, Sanja Stanković, Paul Collinson, Janne Suvisaari, Kari Pulkki, Christopher J. Duff, H Baum, Ana Stavljenić-Rukavina, Kristin M. Aakre, Michel R. Langlois, Päivi Laitinen	7
5	MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia 2019 ·Leukemia & lymphoma ·(unknown), (unknown), Miika Arvonen, Sari Hämäläinen, Esa Jantunen, (unknown), Kari Pulkki, Pekka Riikonen, Auni Juutilainen	5
6	Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock 2019 ·PLoS ONE ·(unknown), Tuukka Tarvasmäki, Veli‐Pekka Harjola, John Parissis, Kari Pulkki, (unknown), Heli Tolppanen, Raija Jurkko, (unknown), (unknown), Alessandro Sionís, José Silva‐Cardoso, Marek Banaszewski, Jindřich Špinar, Alexandre Mebazaa, Johan Lassus, (unknown)	46
7	Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia 2017 ·Disease Markers ·(unknown), (unknown), Sari Hämäläinen, Esa Jantunen, Auni Juutilainen, Kari Pulkki	14
8	Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock 2017 ·Annals of Intensive Care ·Heli Tolppanen, Mercedes Rivas‐Lasarte, Johan Lassus, Jordi Sans‐Roselló, Oliver Hartmann, Matias Greve Lindholm, Mattia Arrigo, Tuukka Tarvasmäki, Lars Køber, Hölger Thiele, Kari Pulkki, Jindřich Špinar, John Parissis, Marek Banaszewski, José Silva‐Cardoso, Valentina Carubelli, Alessandro Sionís, Veli‐Pekka Harjola, Alexandre Mebazaa	60
9	Circulating microRNAs miR-21, miR-122a, miR-320a and miR-423 predict mortality in patients with cardiogenic shock 2016 ·European Heart Journal ·(unknown), (unknown), Johan Lassus, Yvan Devaux, Mélanie Vausort, (unknown), Kari Pulkki, Ilkka Tikkanen, Päivi Lakkisto, Veli‐Pekka Harjola	1
10	Cystatin C as a marker of acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome 2014 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Johan Lassus, Markku S. Nieminen, Keijo Peuhkurinen, Kari Pulkki, Krista Siirilä‐Waris, Reijo Sund, V.‐P. Harjola	0
11	The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43 2008 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Päivi Lakkisto, Csaba Csonka, (unknown), Péter Bencsik, Liisa‐Maria Voipio‐Pulkki, Péter Ferdinándy, Kari Pulkki	21
12	Clinical Significance of Cardiac Troponins I and T in Acute Heart Failure 2008 ·European Journal of Heart Failure ·Tuomo Ilva, Johan Lassus, Krista Siirilä‐Waris, John Melin, Keijo Peuhkurinen, Kari Pulkki, Markku S. Nieminen, Harri Mustonen, Pekka Porela, Veli‐Pekka Harjola	61
13	Cardiomyocyte Apoptosis is Related to Left Ventricular Dysfunction and Remodelling in Dilated Cardiomyopathy, But is not Affected by Growth Hormone Treatment 2006 ·European Journal of Heart Failure ·(unknown), Antti Saraste, Stephan Lindemann, (unknown), Michael Buerke, Harald Darius, Kari Pulkki, Liisa‐Maria Voipio‐Pulkki	27
14	Biochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: Experiences from the Nordic countries 2005 ·Scandinavian Cardiovascular Journal ·Søren Pihlkjær Hjortshøj, Jan Erik Otterstad, Bertil Lindahl, Ragnar Daníelsen, Kari Pulkki, Jan Ravkilde	5
15	Adenosine in Myocardial Protection given through Three Windows of Opportunity. An Experimental Study with Pigs 2001 ·Scandinavian Cardiovascular Journal ·Tommi Vähäsilta, Jyrki K. Virtanen, Antti Saraste, Matti Luotolahti, Kari Pulkki, Mika Valtonen, (unknown), Timo Savunen	9
16	Prediction of Short-Term Outcome in Patients With Suspected Myocardial Infarction 2000 ·Annals of Emergency Medicine ·Pekka Porela, Kari Pulkki, Hans Helenius, Kari Antila, Kim Pettersson, (unknown), L M Voipio-Pulkki	7
17	Prediction of Short-Term Outcome in Patients With Suspected Myocardial Infarction 2000 ·Annals of Emergency Medicine ·Pekka Porela, Kari Pulkki, Hans Helenius, Kari Antila, Kim Pettersson, (unknown), Liisa‐Maria Voipio‐Pulkki	6
18	RT-PCR from Eosinophil-Depleted Leukocytes without RNA Extraction: Cell Selection Using Streptavidin PCR Tubes 2000 ·Clinical Biochemistry ·Mauri M. Hämäläinen, Jarkko Eskola, Jukka Hellman, Kari Pulkki, Allan Rajamäki	1
19	Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure 1997 ·European Heart Journal ·Jyri Lommi, Kari Pulkki, Pekka Koskinen, (unknown), Hannu Leinonen, Matti Härkönen, Markku Kupari	67
20	Blood ketone bodies in congestive heart failure 1996 ·Journal of the American College of Cardiology ·Jyri Lommi, Markku Kupari, Pekka Koskinen, Hannu Näveri, Hannu Leinonen, Kari Pulkki, Matti Härkönen	196

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact